Protein production company Nuclera has raised a $75 million Series C to bring its manufacturing platform to market next ...

Dutch biotech investor Forbion has raised two new funds to put into biotech companies, just 18 months after its last major ...

Novartis used one of its priority review vouchers (PRV) to speed the September approval of Kisqali in early breast cancer, ...

Eli Lilly plans to invest £279 million ($364 million) in the UK as part of a new government partnership in which the ...

Private equity firms TPG and Blackstone are working on a potential deal to buy Brent Saunders-led eye care company Bausch + ...

Seven years ago, Daniel Ives believed that he was on the cusp of solving aging. He wanted to continue working on a discovery ...

More than a year ago, Endpoints News made the decision that we needed a dedicated reporter covering the use of artificial ...

GSK announced another batch of positive data from its respiratory program with the investigational drug depemokimab, this ...

The full results from Pfizer’s pivotal study of its Duchenne muscular dystrophy gene therapy show patients saw no significant ...

Novo Nordisk filed suit against another semaglutide compounder on Friday, bringing its total number of cases to 50. Both Novo ...

Novartis has terminated a mid-stage trial of an oral treatment candidate for idiopathic pulmonary fibrosis, the company ...

The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life ...